ISLAMABAD: The Drug Regulatory Authority of Pakistan (Drap) has initiated a recall of three batches of Dolor DS painkiller syrup, produced by Adamjee Pharmaceuticals, Karachi, after finding that the product lacks sufficient elements necessary for effective patient treatment.
As per a Drap alert, Dolor DS 100mg/5mL Suspension (Batch # 1236, 1237, and 1238) has been identified as deficient in the required quantity of Sodium, posing potential reactions in patients. The regulatory authority cautioned that the use of this painkiller syrup could lead to bodily pain, weakness, throat swelling, and eye infections.
Adamjee Pharmaceuticals has been instructed to cease the supply of the three affected batches in the market.
Consumers have been strongly advised to discontinue the use of this product if it bears the specified batch number(s). They are asked to contact their physicians or healthcare providers if they have encountered any problems related to the use of this painkiller.
The Drap alert directed all pharmacists and chemists operating in distributions and pharmacies to immediately check their stocks and cease the supply of the affected batch. The remaining stock of Dolor DS is to be quarantined and returned to the supplier or the manufacturing company.
To ensure an effective recall of the defective product(s), the regulatory field force of all federating units, including Drap and provincial health departments, has heightened surveillance in the market.
This proactive measure aims to safeguard public health and prevent any potential risks associated with the use of the recalled painkiller syrup.